Shares of Quantum X Labs Inc. QXL have gained 9.3% since the company reported its earnings for the quarter ended June 30, 2026, outperforming the S&P 500 index’s 0.6% decline over the same period. Over the past month, however, the stock has fallen 4.6%, compared with the S&P 500’s 2.2% increase.
Quantum X Labs reported second-quarter 2026 earnings of 12 cents per share against a loss of $1.61 per share.
Revenues of $0.3 million denoted a 20.8% decline from $0.4 million in the year-ago quarter.
Net income was $2.4 million, reversing a net loss of $12.4 million a year earlier. Net income attributable to Quantum X Labs shareholders totaled $2.5 million versus a loss of $11.7 million.
Operating loss widened to $1.4 million from $1 million.
Other Key Business Metrics
Revenues from Gix Media’s Search Platform declined 20.1% to $0.3 million from $0.4 million. Within that business, direct-model revenues fell 41.5% to $0.2 million, while the indirect model generated $0.08 million compared with no revenues a year earlier, supported by third-party strategic partners. Traffic-acquisition and related costs increased 168% to $0.1 million. Research and development expenses surged to $0.2 million from $0.02 million, while general and administrative expenses increased 81.9% to $1 million. Depreciation and amortization edged down to $0.2 million.
Liquidity remained a consideration. At June 30, 2026, Quantum X Labs held $2.4 million in cash and cash equivalents, up from $1 million as of Dec. 31, 2025. Management said the company had $1.9 million of bank and convertible loans and an accumulated deficit of $44.2 million.
Total assets increased to $31.2 million from $10.8 million over the same period, while total equity climbed to $25.8 million from $5 million.
For the six months ended June 30, 2026, net cash used in operating activities from continuing operations widened to $1.7 million from $0.3 million in the year-ago period.
Factors Influencing the Results
Management attributed the decline in direct-model revenues to changes and updates in internet-browser technology that reduced the scale of product distribution. Conversely, indirect-model revenues benefited from third-party strategic partners. The acquisition of Quantum Israel drove the substantial increase in R&D expenses and contributed to higher G&A costs, alongside increased professional-services expenses following the company’s Nasdaq uplisting.
The quarter’s reported profit was heavily influenced by a $3.8 million gain from the deconsolidation of CliniQuantum after Quantum Israel lost control of the business. Net financial expenses also fell sharply to $0.1 million from $7.7 million, primarily because the prior-year period included expenses tied to financial instruments measured at fair value. Other expenses decreased to $0.1 million from $0.5 million.
Management Commentary and Outlook
Quantum X Labs said its quantum strategy uses separate operating entities to diversify technical risk, pursue tailored commercialization plans, share intellectual property and facilitate partnerships with academic institutions, government laboratories and industry participants. Management is also responding to liquidity pressures through reductions in salaries, professional services and other operating expenses while pursuing new partnerships and income sources.
Management anticipates that revenues from internet-browser add-ons will continue to decline because of browser technology changes.
Other Developments
Quantum X Labs completed its acquisition of Quantum Israel on March 4, 2026, making it a wholly owned subsidiary and expanding the company into quantum computing, sensing, navigation and security. During June, a third party acquired 54% of CliniQuantum, causing Quantum Israel to lose control. Quantum X Labs subsequently accounted for its remaining CliniQuantum investment under the equity method at a fair value of $3.8 million and recognized the related $3.8 million deconsolidation gain.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Quantum X Labs Inc. (QXL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
